Phantom Gets CFTC's 'No-Action' Pass: A Rare Case of Permission Over Pardon

In a move that’s about as common as a rational degen, the U.S. Commodity Futures Trading Commission (CFTC) has handed a no-action letter to crypto wallet provider Phantom Technologies. The letter, from the division that oversees market participants, essentially says the regulator will look the other way if Phantom doesn't register as a broker, provided it sticks to a very specific script. It's the regulatory equivalent of a hall pass, but for navigating the labyrinth of financial law.

Phantom, perhaps tired of the "build now, lawyer up later" startup playbook, says this green light lets it "act as a non-custodial interface connecting users to a registered exchange [...] without taking on the regulatory obligations of an introducing broker." The company proudly noted it asked for permission first, a strategy in crypto that’s often viewed with the same skepticism as a "fully diluted valuation" promise.

This letter marks one of the first no-action responses for a crypto firm under CFTC Chair Michael Selig, who finally got his Senate confirmation badge in December. Selig and former acting chair Caroline Pham were running the show under the previous administration when the CFTC dished out similar "proceed with caution" notes to platforms like Polymarket and Binomial. It seems the playbook for prediction markets is getting dog-eared.

Chairman Selig remains the staunch defender of the CFTC's "exclusive jurisdiction" over prediction markets like Kalshi and Polymarket, even as state attorneys general sharpen their knives, crying foul over gambling laws. Just last week, flying solo as the only commissioner, he proposed a new rule to tweak regulations for event contracts, throwing the proposal into the public comment arena—a digital coliseum where every anon has an opinion.

While this regulatory chess game plays out, the CFTC and its frenemy, the Securities and Exchange Commission (SEC), signed a memorandum of understanding last week. They've agreed to try a "minimum effective dose" regulatory strategy, an attempt to call a ceasefire in their long-running "regulatory turf wars." It's a détente that has the entire industry watching, wondering if it'll last longer than a memecoin pump.